Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | H | MAR |
|---|---|---|
| Price | $159.77 | $353.50 |
| Change today | ▲ 0.76% | ▼ 0.61% |
| Market cap | $15.06B | $92.18B |
| Return, 3 months | -16.2% | -3.8% |
| Return, year to date | -0.1% | +14.6% |
| Return, 1 year | +11.3% | +36.2% |
| P/E (TTM) | 197.2 | 36.6 |
| P/B | 4.6 | -20.4 |
| P/E percentile vs own 5y | 92nd | 76th |
| Dividend yield | 0.38% | 0.78% |
| Revenue growth (YoY, latest qtr) | +1.2% | +4.8% |
| Net profit growth (YoY) | +2,825.0% | +0.4% |
| Gross margin | 19.9% | 20.1% |
| Operating margin | 7.1% | 15.7% |
| Net margin | 1.1% | 9.6% |
| Return on equity | 2.3% | – |
| Analyst target vs. price | +23.9% | +10.7% |
| Analyst buy share | 64% | 50% |
| RSI (14) | 41 | 62 |
| 30-day volatility | 25.2% | 19.3% |
| Max drawdown, 1 year | -23.3% | -18.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
